Age-Related Macular Degeneration (AMD) affects the macula, the central part of the retina responsible for sharp, detailed vision. It is a leading cause of vision loss in people over 50. AMD has two forms: dry (atrophic) which progresses slowly, and wet (neovascular) which can cause rapid, severe vision loss due to abnormal blood vessel growth.
AMD results from deterioration of the retinal pigment epithelium and photoreceptor cells in the macula. In wet AMD, abnormal blood vessels grow beneath the retina (choroidal neovascularization), leaking blood and fluid that damage the macula. The exact cause involves a combination of genetic, environmental, and aging factors.
The primary treatment for wet AMD. Regular injections of anti-VEGF agents can stabilize or improve vision by reducing abnormal vessel growth and leakage.
AREDS2 formula (vitamins C, E, zinc, lutein, zeaxanthin) can slow progression of intermediate dry AMD by approximately 25%.
Regular OCT scans and Amsler grid self-testing help detect conversion from dry to wet AMD early, when treatment is most effective.
Direct delivery of medication near the retina for conditions where eye drops cannot reach.
View treatmentNon-invasive retinal scan providing layer-by-layer analysis of retinal structure.
View treatmentSpecialized retinal vessel imaging using fluorescent dye injection and sequential photography.
View treatmentEarly detection and expert care make all the difference. Book a consultation with Dr. Pawan Gupta today.
Book Consultation